Influence of plasma glutathione levels on radiation mucositis

International Journal of Radiation Oncology Biology Physics

Volumn 51, Issue 2, 2001, Pages 460-464

  Wardman, Peter ^a,b   Folkes, Lisa K ^a   Bentzen, Soren M ^a   Stratford, Michael R L ^a   Hoskin, Peter J ^b   Phillips, H ^b   Jackson, S ^b  

^a Gray Cancer Institute   (United Kingdom)

^b MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

Antioxidants; Dysphagia; Glutathione; Mucositis; Radiotherapy

Indexed keywords

ANTIOXIDANTS; BLOOD; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PATIENT TREATMENT; TUMORS;

DYSPHAGIA SCORES;

RADIOTHERAPY;

GLUTATHIONE; THIOL;

ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HEAD AND NECK CANCER; HUMAN; MUCOSA INFLAMMATION; PRIORITY JOURNAL; RADIATION INJURY;

EID: 0035479086     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)01612-1     Document Type: Letter

References (31)

1. Influence of plasma GSH level on acute radiation mucositis of the oral cavity
2. The recording of morbidity related to radiotherapy
3. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)
4. Overview. Late effects of normal tissues (LENT) scoring system
5. Investigation of the hereditary haemolytic anaemias
6. Analysis of biological thiols; Quantitative determination of thiols at the picomole level based upon derivatization with monobromobimanes and separation by cation-exchange chromatography
7. Measurement of allantoin and uric acid in human body fluids. A potential index of free-radical reactions in vivo?
8. Selected methods for the determination of ascorbic acid in animal cells, tissues, and fluids
9. The level and half-life of glutathione in human plasma
10. Some pitfalls in the measurement of blood glutathione
11. Glutathione measurement in human plasma. Evaluation of sample collection, storage and derivatization conditions for analysis of dansyl derivatives by HPLC
12. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer; A hypothesis
13. Stabilization of ascorbic acid in human plasma, and its liquid-chromatographic measurement
14. Profiles of antioxidants in human plasma
15. Plasma glutathione levels in health and in patients with malignant disease
16. Plasma total glutathione in humans and its association with demographic and health-related factors
17. Quantification of glutathione and glutathione disulfide in human plasma
18. Method for determination of free and total glutathione and γ-glutamylcysteine concentrations in human leukocytes and plasma
19. Determination of reduced, oxidized, and protein-bound glutathione in human plasma with precolumn derivatization with monobromobimane and liquid chromatography
20. High-dose intravenous glutathione in man. Pharmacokinetics and effects on cyst(e)ine in plasma and urine
21. Blood and plasma glutathione measured in healthy subjects by HPLC; Relation to sex, aging, biological variables, and life habits
22. Glutathione in human plasma; Decline in association with aging, age-related macular degeneration, and diabetes
23. Redox state of glutathione in human plasma
24. Thiols as a measure of plasma redox status in healthy subjects and in patients with renal or liver failure
25. Status of glutathione and other thiols and disulfides in human plasma
26. Possible role of glutathione in predicting radiotherapy resonse of cervix cancer
27. Effect of ifosfamide treatment on glutathione and glutathione conjugation activity in patients with advanced cancers
28. Influence of treatment with aminoglutethimide on plasma and red-blood-cell glutathione status in breast cancer patients
29. Improved method for the determination of blood glutathione
30. Microregional heterogeneity of non-protein thiols in cervical carcinomas assessed by combined use of HPLC and fluorescence image analysis
31. Cysteine concentrations in rodent tumors; Unexpectedly high values may cause therapy resistance